share_log

Novartis Q4 2024 Adj. EPS $1.98 Beats $1.81 Estimate, Sales $13.153B Beat $12.811B Estimate

Novartis Q4 2024 Adj. EPS $1.98 Beats $1.81 Estimate, Sales $13.153B Beat $12.811B Estimate

诺华2024年第四季度调整后每股收益为1.98美元,超出1.81美元的预期,销售额为131.53亿,超过128.11亿的预期。
Benzinga ·  01/31 07:18

Novartis (NYSE:NVS) reported quarterly earnings of $1.98 per share which beat the analyst consensus estimate of $1.81 by 9.39 percent. This is a 29.41 percent increase over earnings of $1.53 per share from the same period last year. The company reported quarterly sales of $13.153 billion which beat the analyst consensus estimate of $12.811 billion by 2.67 percent. This is a 15.14 percent increase over sales of $11.423 billion the same period last year.

诺华(纽交所:NVS)报告的季度每股收益为1.98美元,超过了分析师一致预期的1.81美元,超出幅度为9.39%。这是与去年同期每股收益1.53美元相比增长了29.41%。公司报告的季度销售额为131.53亿,超过了分析师一致预期的128.11亿,超出幅度为2.67%。这与去年同期销售额114.23亿相比增长了15.14%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
评论 评论 · 浏览 405

热点推荐

抢沙发

声明

本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。